- Year Founded: 2008
- Headquarters: Guangzhou,China
- Estimated Employees: N/A
- Product Lines:
- Viral Hepatitis & AIDS
- STDs
- Cancer Related Bio-markers
- Prenatal and Postnatal Care
- Respiratory Tract Diseases
- Digestive Tract Diseases
- Real Time PCR System
- Products:
- MA6000 Real-time quantitative PCR system
- Natch S Fully Automated Nucleic Acid Extraction System
- HBV/HSV-2 DNA Quantitative Fluorescence
- HCV Genotyping
- HPV(16/18) DNA Fluorescence Diagnostic Kit (PCR-Fluorescence Probing)
Novel Coronavirus(2019-nCoV) Nucleic Acid Diagnostic Kit(PCR-Fluorescence Probing)
Slan 96P Real Time PCR System
HIV RNA Quantitative Fluorescence Diagnostic Kit (PCR Fluorescence Probing)
MP DNA Fluorescence Diagnostic Kit (PCR-Fluorescence Probing)
Sansure Biotech Inc. was founded in 2008 as a dedicated company developing and manufacturing a complete product line for molecular laboratories, ranging from upstream nucleic acid extraction kits and full automation to downstream real time PCR diagnostic & research kits and fluorescence systems.
Based on innovative R&D center in Changsha, China, Sansure understands its capability and social responsibility to offer molecular diagnostic products consistent in quality, accurate and reliable in test results, easy to use and accessible to laboratories of all levels despite their variety in lab environment.
Sansure is gradually winning its reputation all over the world and exerting growing influence on popularizing qPCR technologies towards what they are supposed to be as affordable and accessible human health care means.
Sansure has cooperated with more than 2000 hospitals and laboratories contributing to daily consumption of over 100,000 tests.Nine out of the ten top hospitals specialized in infectious diseases are Sansure loyal clients.
Globally, Sansure innovative technologies now have been introduced into more than 40 countries and regions including Europe, Middle East, Asia, Africa and South and Central America where Sansure has received recognition.
